65
Participants
Start Date
June 25, 2021
Primary Completion Date
April 6, 2023
Study Completion Date
April 6, 2023
UBX1325
Patients will be administered a single 50 μL UBX1325 IVT injection
Sham
Sham procedure
New York Eye and Ear Infirmary, New York
Cumberland Valley Retina Consultants, Hagerstown
Retina Consultants of Carolina, PA, Greenville
Bascom Palmer Eye Institute, Miami
MedEye Associates, Miami
MidWest Eye Institute, Indianapolis
Northwestern Medical Group, Chicago
Retina Center of Texas, Southlake
Valley Retina Institute, P.A., McAllen
Advanced Vision Research Institute, Longmont
Retinal Research Institute, LLC, Phoenix
Sierra Eye Associates, Reno
The Retina Partners, Encino
Loma Linda University, Loma Linda
Salehi Retina Institute Inc., Huntington Beach
California Retina Consultants, Oxnard
California Retina Consultants, Bakersfield
EyeHealth Northwest, Portland
Mass Eye and Ear Institute, Boston
Alberta Retina Research Corporation, Edmonton
Toronto Retina Institute, North York
Hopital Maisonneuve-Rosemont, Montreal
Unity Biotechnology, Inc.
INDUSTRY